A study to assess the effect of AZD0780 on the pharmacokinetics of rosuvastatin.

Trial Identifier:	D7960C00002
Sponsor:	AstraZeneca
NCTID::	NCT05787002
Start Date:	March 2023
Primary Completion Date:	May 2023
Study Completion Date:	May 2023
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, MD	Brooklyn, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.